Search Results

Filter
  • 1-10 of  12,898 results for ""Stathmin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma.

  • Authors : Davidson B; Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, Norway.; Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.

Subjects: Stathmin*/Stathmin*/Stathmin*/metabolism ; Leiomyosarcoma*/Leiomyosarcoma*/Leiomyosarcoma*/pathology ; Leiomyosarcoma*/Leiomyosarcoma*/Leiomyosarcoma*/mortality

  • Source: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists [Int J Gynecol Pathol] 2025 Jan 01; Vol. 44 (1), pp. 56-66. Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8214845 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The role of stathmin expression in the differential diagnosis, prognosis, and potential treatment of ovarian sex cord-stromal tumors.

  • Authors : Šafanda A; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic.; Kendall Bártů M

Subjects: Stathmin*/Stathmin*/Stathmin*/analysis ; Stathmin*/Stathmin*/Stathmin*/metabolism ; Sex Cord-Gonadal Stromal Tumors*/Sex Cord-Gonadal Stromal Tumors*/Sex Cord-Gonadal Stromal Tumors*/pathology

  • Source: Diagnostic pathology [Diagn Pathol] 2024 Aug 30; Vol. 19 (1), pp. 118. Date of Electronic Publication: 2024 Aug 30.Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-1596

Record details

×
Academic Journal

STMND1 is a phylogenetically ancient stathmin which localizes to motile cilia and exhibits nuclear translocation that is inhibited when soluble tubulin concentration increases.

  • Authors : Deng X; Department of Systems Biology, Harvard Medical School, Boston, MA 02115.; Seguinot BO

Subjects: Cilia*/Cilia*/Cilia*/metabolism ; Tubulin*/Tubulin*/Tubulin*/metabolism ; Stathmin*/Stathmin*/Stathmin*/metabolism

  • Source: Molecular biology of the cell [Mol Biol Cell] 2024 Jun 01; Vol. 35 (6), pp. ar82. Date of Electronic Publication: 2024 Apr 17.Publisher: American Society for Cell Biology Country of Publication: United States NLM ID: 9201390 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Targeting STMN2 for neuroprotection and neuromuscular recovery in Spinal Muscular Atrophy: evidence from in vitro and in vivo SMA models.

  • Authors : Pagliari E; Department of Pathophysiology and Transplantation, Dino Ferrari Center, University of Milan, Milan, Italy.; Taiana M

Subjects: Stathmin*/Stathmin*/Stathmin*/metabolism ; Stathmin*/Stathmin*/Stathmin*/genetics ; Muscular Atrophy, Spinal*/Muscular Atrophy, Spinal*/Muscular Atrophy, Spinal*/therapy

  • Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 Dec 27; Vol. 82 (1), pp. 29. Date of Electronic Publication: 2024 Dec 27.Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071

Record details

×
Academic Journal

Stathmin 2 is a potential treatment target for TDP-43 proteinopathy in amyotrophic lateral sclerosis.

  • Authors : Liu Y; Key Laboratory of Brain, Cognition and Education Sciences, South China Normal University, Ministry of Education, Guangzhou, China.; Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, 510631, China.

Subjects: Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/complications ; Stathmin*/Stathmin*/Stathmin*/antagonists & inhibitors ; TDP-43 Proteinopathies*/TDP-43 Proteinopathies*/TDP-43 Proteinopathies*/drug therapy

  • Source: Translational neurodegeneration [Transl Neurodegener] 2024 Apr 11; Vol. 13 (1), pp. 20. Date of Electronic Publication: 2024 Apr 11.Publisher: BioMed Central Country of Publication: England NLM ID: 101591861 Publication Model: Electronic Cited Medium: Print ISSN: 2047-9158

Record details

×
Academic Journal

Two cardinal features of ALS, reduced STMN2 and pathogenic TDP-43, synergize to accelerate motor decline in mice.

  • Authors : Krus KL; Department of Developmental Biology, Washington University School of Medicine, St. Louis 63110, United States.; Benitez AM

Subjects: Stathmin*/Stathmin*/Stathmin*/genetics ; Stathmin*/Stathmin*/Stathmin*/metabolism ; Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/genetics

  • Source: Experimental neurology [Exp Neurol] 2025 Feb; Vol. 384, pp. 115068. Date of Electronic Publication: 2024 Nov 26.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The C-terminus of stathmin-like proteins governs the stability of their complexes with tubulin.

  • Authors : Campanacci V; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.; Gigant B

Subjects: Stathmin*/Stathmin*/Stathmin*/metabolism ; Tubulin*/Tubulin*/Tubulin*/metabolism; Microtubule Proteins/Microtubule Proteins/Microtubule Proteins/analysis

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2023 Nov 19; Vol. 682, pp. 244-249. Date of Electronic Publication: 2023 Oct 06.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Microtubules, Membranes, and Movement: New Roles for Stathmin-2 in Axon Integrity.

Subjects: Stathmin*/Stathmin*/Stathmin*/metabolism ; Microtubules*/Microtubules*/Microtubules*/metabolism ; Axons*/Axons*/Axons*/metabolism

  • Source: Journal of neuroscience research [J Neurosci Res] 2024 Sep; Vol. 102 (9), pp. e25382.Publisher: Wiley Interscience Country of Publication: United States NLM ID: 7600111 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway.

  • Authors : Zhang K; Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China.; Li JY

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Stathmin*/Stathmin*/Stathmin*/metabolism ; Stathmin*/Stathmin*/Stathmin*/genetics

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2024 Jun; Vol. 103 (6), pp. e14559.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print Cited Medium: Internet ISSN: 1747-0285

Record details

×
Academic Journal

The relationship between stathmin-2 level and metabolic parameters in newly diagnosed type 2 diabetes mellitus patients.

  • Authors : Demir I; Health Sciences University, Izmir Bozyaka Training and Research Hospital, Department of Internal Medicine, Karabaglar, Izmir, Turkey. Electronic address: .; Yilmaz I

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism

  • Source: The American journal of the medical sciences [Am J Med Sci] 2024 Jul; Vol. 368 (1), pp. 25-32. Date of Electronic Publication: 2024 Apr 03.Publisher: Elsevier Country of Publication: United States NLM ID: 0370506 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  12,898 results for ""Stathmin""